Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
[6] [7] Effects on energy expenditure have been observed in early-phase and preclinical work, but this finding requires confirmation in larger trials
References New England Journal of Medicine - Retatrutide Phase 2 Trial - Primary efficacy and safety data for retatrutide New England Journal of Medicine - SURMOUNT-1 Trial - Tirzepatide obesity trial results FDA - Zepbound (Tirzepatide) Approval - FDA approval information for tirzepatide ClinicalTrials.gov - Retatrutide Studies - Ongoing Phase 3 clinical trials ClinicalTrials.gov - Retatrutide Phase 3 trials Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice
Curr Neuropharmacol 17(4):377402
Taking that first step could make a lasting difference in your overall health and well-being.
